Simon Drescher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Simon Drescher has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Annette Meister
Interdisciplinary Research Center HALOmem, MLU Halle-Wittenberg, Charles Tanford Protein Center, Kurt-Mothes-Str. 3a, 06120 Halle (Saale), Germany; Institute of Biochemistry and Biotechnology-Physical Biotechnology, Charles Tanford Protein Center, MLU Halle-Wittenberg, Kurt-Mothes-Str. 3a, 06120 Halle (Saale), Germany
34 shared publicationsAlfred Blume
Phospholipid Research Center, Im Neuenheimer Feld 515 D-69120, Heidelberg, Germany; Martin-Luther-University Halle-Wittenberg, Institute of Chemistry - Physical Chemistry, von-Danckelmann-Platz 4 D-06120, Halle (Saale), Germany
25 shared publicationsBodo Dobner
Institute of Pharmacy, Martin Luther University (MLU) Halle-Wittenberg , Wolfgang-Langenbeck-Str. 4, 06120 Halle (Saale), Germany
24 shared publicationsGerd Hause
Biocenter, MLU Halle-Wittenberg, Weinbergweg 22, 06120 Halle (Saale), Germany
18 shared publications- Annette Meister
Interdisciplinary Research Center HALOmem, Charles Tanford Protein Center Institute of Biochemistry and Biotechnology Martin Luther University Halle-Wittenberg 06120 Halle Germany
12 shared publications Vasil M. Garamus
Helmholtz-Zentrum Hereon, Max-Planck-Str. 1, 21502 Geesthacht, Germany
11 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 220, 107494
Call for data: High dose empty liposome control data for a collaborative open access publication (>LIPOTOX<)
- 1 March 2026
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 220, 107494
Open AccessCall for data: High dose empty liposome control data for a collaborative open access publication (>LIPOTOX<)
- Open Access
- 19 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 215, 107334
Special issue: Phospholipids as functional ingredients in pharmaceutical formulations: Current advances and perspectives
- 19 October 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 215, 107334
Open AccessSpecial issue: Phospholipids as functional ingredients in pharmaceutical formulations: Current advances and perspectives
- Open Access
- 13 May 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 210, 107126
The 8th International Symposium on Phospholipids in Pharmaceutical Research – An update on current research in phospholipids presented at the biennial symposium of the Phospholipid Research Center Heidelberg
- 13 May 2025
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 210, 107126
Open AccessThe 8th International Symposium on Phospholipids in Pharmaceutical Research – An update on current research in phospholipids presented at the biennial symposium of the Phospholipid Research Center Heidelberg
- 13 July 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1864 (10) , 184004
Azide- and diazirine-modified membrane lipids: Physicochemistry and applicability to study peptide/lipid interactions via cross-linking/mass spectrometry
- 13 July 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1864 (10) , 184004
Azide- and diazirine-modified membrane lipids: Physicochemistry and applicability to study peptide/lipid interactions via cross-linking/mass spectrometry
- Open Access
- 29 January 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 212, 112369
Investigating bolalipids as solubilizing agents for poorly soluble drugs: Effects of alkyl chain length on solubilization and cytotoxicity
- 29 January 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 212, 112369
Open AccessInvestigating bolalipids as solubilizing agents for poorly soluble drugs: Effects of alkyl chain length on solubilization and cytotoxicity
- Open Access
- 18 August 2021
- Published by Wiley in Chemistry – A European Journal
- Vol. 27 (59) , 14586-14593
A Diazirine‐Modified Membrane Lipid to Study Peptide/Lipid Interactions – Chances and Challenges
Although incorporation of photo‐activatable lipids into membranes potentially opens up novel avenues for investigating interactions with proteins, the question of whether diazirine‐modified lipids are suitable for such studies, remains under debate. Focusing on the potential for studying lipid/peptide interactions by cross‐linking mass spectrometry (XL‐MS), we developed a diazirine‐modified lipid (DiazPC), and examined its behaviour in membranes incorporating the model α‐helical peptide LAVA20. We observed an unexpected backfolding of the diazirine‐containing stearoyl chain of the lipid. This surprising behaviour challenges the potential application of DiazPC for future XL‐MS studies of peptide and protein/lipid interactions. The observations made for DiazPC most likely represent a general phenomenon for any type of membrane lipids with a polar moiety incorporated into the alkyl chain. Our finding is therefore of importance for future protein/lipid interaction studies relying on modified lipid probes.
- 18 August 2021
- Published by Wiley in Chemistry – A European Journal
- Vol. 27 (59) , 14586-14593
Open AccessA Diazirine‐Modified Membrane Lipid to Study Peptide/Lipid Interactions – Chances and Challenges
Although incorporation of photo‐activatable lipids into membranes potentially opens up novel avenues for investigating interactions with proteins, the question of whether diazirine‐modified lipids are suitable for such studies, remains under debate. Focusing on the potential for studying lipid/peptide interactions by cross‐linking mass spectrometry (XL‐MS), we developed a diazirine‐modified lipid (DiazPC), and examined its behaviour in membranes incorporating the model α‐helical peptide LAVA20. We observed an unexpected backfolding of the diazirine‐containing stearoyl chain of the lipid. This surprising behaviour challenges the potential application of DiazPC for future XL‐MS studies of peptide and protein/lipid interactions. The observations made for DiazPC most likely represent a general phenomenon for any type of membrane lipids with a polar moiety incorporated into the alkyl chain. Our finding is therefore of importance for future protein/lipid interaction studies relying on modified lipid probes.
- 23 February 2021
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 23 (9) , 5325-5339
Influence of a single ether bond on assembly, orientation, and miscibility of phosphocholine lipids at the air–water interface
How does a small change in the structure of a phospholipid affect its supramolecular assembly? In aqueous suspensions, the substitution of one ester linkage in DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) by an ether linkage alters its phase behaviour completely. To unravel the effect of replacing a phospholipid's ester linkage by an ether linkage in lipid monolayers, we characterized pure monolayers of the model lipid DPPC and its sn-2 ether analogue PHPC (1-palmitoyl-2-O-hexadecyl-sn-glycero-3-phosphocholine) as well as mixtures of both by measurements of surface pressure–molecular area (π–Amol) isotherms. In addition, we used infrared reflection absorption spectroscopy (IRRAS) to study lipid condensation, lipid chain orientation, headgroup hydration, and lipid miscibility in all samples. Mixed monolayers consisting of DPPC and PHPC were studied further using epifluorescence microscopy. Our results indicate a strong influence of the sn-2 ether linkage on headgroup hydration and ordering effects in the regions of the apolar chains and the headgroups. Both effects could originate from changes in glycerol conformation. Furthermore, we observed a second plateau in the π–Amol isotherms of DPPC/PHPC mixtures and analysis of the mixed π–Amol isotherms reveals a non-ideal mixing behaviour of both lipids which may be caused by conformational differences in their headgroups.
- 23 February 2021
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 23 (9) , 5325-5339
Influence of a single ether bond on assembly, orientation, and miscibility of phosphocholine lipids at the air–water interface
How does a small change in the structure of a phospholipid affect its supramolecular assembly? In aqueous suspensions, the substitution of one ester linkage in DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) by an ether linkage alters its phase behaviour completely. To unravel the effect of replacing a phospholipid's ester linkage by an ether linkage in lipid monolayers, we characterized pure monolayers of the model lipid DPPC and its sn-2 ether analogue PHPC (1-palmitoyl-2-O-hexadecyl-sn-glycero-3-phosphocholine) as well as mixtures of both by measurements of surface pressure–molecular area (π–Amol) isotherms. In addition, we used infrared reflection absorption spectroscopy (IRRAS) to study lipid condensation, lipid chain orientation, headgroup hydration, and lipid miscibility in all samples. Mixed monolayers consisting of DPPC and PHPC were studied further using epifluorescence microscopy. Our results indicate a strong influence of the sn-2 ether linkage on headgroup hydration and ordering effects in the regions of the apolar chains and the headgroups. Both effects could originate from changes in glycerol conformation. Furthermore, we observed a second plateau in the π–Amol isotherms of DPPC/PHPC mixtures and analysis of the mixed π–Amol isotherms reveals a non-ideal mixing behaviour of both lipids which may be caused by conformational differences in their headgroups.
- Open Access
- 28 January 2021
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 123 (4) , 2000297
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
- 28 January 2021
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 123 (4) , 2000297
Open AccessThe Use of Phospholipids to Make Pharmaceutical Form Line Extensions
- Open Access
- 18 December 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (12) , 1235
The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery
This review summarizes the research on phospholipids and their use for drug delivery related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that have been approved by the PRC since 2017 and are currently still ongoing or have recently been completed. The different projects cover all facets of phospholipid research, from basic to applied research, including the use of phospholipids in different administration forms such as liposomes, mixed micelles, emulsions, and extrudates, up to industrial application-oriented research. These projects also include all routes of administration, namely parenteral, oral, and topical. With this review we would like to highlight possible future research directions, including a short introduction into the world of phospholipids.
- 18 December 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (12) , 1235
Open AccessThe Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery
This review summarizes the research on phospholipids and their use for drug delivery related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that have been approved by the PRC since 2017 and are currently still ongoing or have recently been completed. The different projects cover all facets of phospholipid research, from basic to applied research, including the use of phospholipids in different administration forms such as liposomes, mixed micelles, emulsions, and extrudates, up to industrial application-oriented research. These projects also include all routes of administration, namely parenteral, oral, and topical. With this review we would like to highlight possible future research directions, including a short introduction into the world of phospholipids.